Celyad Oncology SA (DUS:1C0) Financings

Celyad Oncology SA

Financings

RaiseDateIn US dollars
Private placement of capital increase (shares)
Closed: €500,000 raised · €0.2 a share
Buyers: CFIP CLYD (UK) Limited (€500,000 for 2,500,000 shares; expected to hold approximately 60.52% of outstanding shares and approximately 68.75% of voting rights); an affiliate of Fortress Investment Group (2,500,000 new shares)
Insiders: Fortress, a related party through its shareholding and board representation, is the subscriber; its nominated directors did not take part in the board deliberations or votes.
Use of proceeds: Working capital and general corporate purposes
Sep 23, 2026US$569,630
Private placement of newly issued ordinary shares
Announced: €1M · €0.3 a share
Buyers: CFIP CLYD (UK) Limited (€1 million for 3,333,333 newly issued ordinary shares; expected to hold approximately 58.51% of the Company's shares)
Insiders: Fortress, a related party of the Company, is the sole subscriber and is expected to hold approximately 58.51% of the shares
Use of proceeds: Working capital for general corporate purposes; extend cash runway to mid Q4 2025
Jul 28, 2025US$1.16M

Read by 6ix AI from the company's releases